133
Participants
Start Date
December 31, 2014
Primary Completion Date
October 30, 2017
Study Completion Date
October 30, 2017
IMM-124E
IMM-124E
Placebo
Matched placebo
Westmead Hospital, Westmead
The Nepean Hospital, Penrith
The Alfred Hospital, Prahran
Royal Melbourne Hospital, Parkville
Box Hill Hospital, Box Hill
Princess Alexandra Hospital, Woolloongabba
University of Virginia Medical Centre, Charlottesville
Bon Secours St Marys Hospital, Richmond
Virginia Commonwealth University, Richmond
Mary Immaculate Hospital, Newport News
Duke Liver Centre, Durham
University of Florida Hepatology Research at CTRB, Gainesville
Cleveland Clinic, Cleveland
Northwestern Memorial Hospital, Chicago
Kansas City Research Institute, Kansas City
Sourasky Medical Center (Ichilov), Tel Aviv
Baylor St Lukes Medical Centre, Houston
Pinnacle Clinical Research, Live Oak
Brooke Army Medical Centre, Houston
University of Colorado, Aurora
eStudySite, Chula Vista
University of California San Diego, San Diego
Quest Clinical Research, San Francisco
Swedish Medical Centre, Seattle
Hadassah Medical Centre, Jerusalem
Lead Sponsor
Immuron Ltd.
INDUSTRY